Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
GW Pharmaceuticals
GW Pharmaceuticals
Activities:
Ingredients
Research & Development
X
LinkedIn
Trending Articles
Arla Foods Ingredients new beverage concept for nutrition-conscious gamers
The energy drink contains 15g of protein, taurine, magnesium, zinc, caffeine and vitamins A, B3, B6 and B12
The role of traceability in the nutraceutical supply chain
The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...
The power of the pomegranate in bolstering gut health
Supplementation with Punica granatum extract can help to enhance gut health in three ways, a novel study finds
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
Lubrizol to showcase microencapsulation technology at Vitafoods Europe 2024
The company will showcase technologies that assist in iron delivery for incorporation into supplement formulations
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Finance
GW Pharmaceuticals reports Epidiolex sales of $296 million in first year
The British biopharmaceutical company has released Q4 and 2019 financial year results
Manufacturing
Momentum in the US cannabidiol market gains retailers' attention
Walmart and other big-name stores in talks with food and drinks makers in preparation for the day CBD-enriched products are allowed on the shelves
Regulatory
First prescription CBD from GW Pharma has restriction lowered
The US Drug Enforcement Administration’s decision to move Epidiolex to Schedule V was based on non-clinical and clinical data that evaluated the medicine’s potential for abuse
Ingredients
Marijuana derivative reduces seizures in children and young adults with treatment-resistant epilepsy
New open-label trial of prescription cannabidiol shows overall safety and efficacy
Subscribe now